Business Description
Avalyn Pharma is a Boston-based clinical-stage company working to improve treatment for rare lung diseases, particularly pulmonary fibrosis. Rather than relying on pills, the company delivers established medications directly to the lungs through inhalation, aiming to make them more effective and better tolerated. Its lead programs include inhaled versions of two proven drugs, as well as a combination therapy that targets the disease through two different pathways at once.
